Press Announcements - FDA.gov

1. Press Announcements  FDA.gov
2. FDA Approves Siponimod (Mayzent) for Multiple Sclerosis  Medscape
3. Novartis gets U.S. approval for new drug to treat multiple sclerosis  Reuters
4. FDA approves drug for relapsing form of Multiple sclerosis  Specialty Medical Dialogues
5. View full coverage on Google News

(CLICK HERE TO READ AND SEE MORE)